CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
43.30
-1.43 (-3.20%)
At close: Dec 5, 2025, 4:00 PM EST
43.67
+0.37 (0.85%)
After-hours: Dec 5, 2025, 6:24 PM EST
CG Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 45.15 | 257.07 | 8.27 | 88.14 | 53.61 |
| Short-Term Investments | 635.12 | 484.93 | 179.41 | 55.34 | - |
| Cash & Short-Term Investments | 680.26 | 742 | 187.67 | 143.48 | 53.61 |
| Cash Growth | 25.81% | 295.37% | 30.80% | 167.65% | - |
| Other Receivables | - | 0.78 | 0.09 | 0.3 | 0 |
| Receivables | 0.52 | 0.78 | 0.09 | 0.3 | 0 |
| Prepaid Expenses | 13.51 | 11.43 | 6.36 | 3.42 | 4.8 |
| Total Current Assets | 695.79 | 754.21 | 194.12 | 147.21 | 58.41 |
| Property, Plant & Equipment | 19.53 | 0.49 | 0.49 | 0.51 | 0.2 |
| Long-Term Deferred Charges | - | - | 4.67 | - | - |
| Other Long-Term Assets | 0.11 | 0.09 | 0.02 | 0.03 | 0.09 |
| Accounts Payable | 9.19 | 6.52 | 3.24 | 0.99 | 1 |
| Accrued Expenses | 19.62 | 14.23 | 9.68 | 5.12 | 1.89 |
| Current Portion of Long-Term Debt | - | - | - | 8.97 | 2.94 |
| Current Portion of Leases | 0.91 | 0.19 | 0.22 | 0.19 | 0.07 |
| Other Current Liabilities | 0.54 | 0.44 | 1.12 | 0.17 | 0.07 |
| Total Current Liabilities | 30.53 | 21.37 | 14.25 | 15.43 | 5.98 |
| Long-Term Debt | 3 | - | - | 6.53 | 12.06 |
| Long-Term Leases | 3.33 | 0.05 | 0.24 | 0.26 | 0.05 |
| Other Long-Term Liabilities | 3.8 | - | 0.01 | 0.35 | 0.35 |
| Common Stock | 0.01 | 0.01 | - | - | 0 |
| Additional Paid-In Capital | 1,025 | 951.35 | 6.84 | 3.64 | 3.27 |
| Retained Earnings | -337.67 | -217.98 | -129.94 | -81.34 | -45.89 |
| Total Common Equity | 687.64 | 733.38 | -123.1 | -77.69 | -42.62 |
| Total Liabilities & Equity | 729.91 | 754.8 | 199.3 | 147.75 | 58.69 |
| Total Debt | 7.24 | 0.24 | 0.46 | 15.94 | 15.13 |
| Net Cash (Debt) | 673.02 | 741.76 | 187.21 | 127.54 | 38.48 |
| Net Cash Growth | 24.54% | 296.21% | 46.79% | 231.45% | - |
| Net Cash Per Share | 9.03 | 11.87 | 43.23 | 34.09 | 10.54 |
| Filing Date Shares Outstanding | 80.67 | 76.22 | 66.64 | 3.84 | 3.65 |
| Total Common Shares Outstanding | 78.28 | 76.15 | 5.22 | 3.84 | 3.65 |
| Working Capital | 665.26 | 732.84 | 179.87 | 131.78 | 52.43 |
| Book Value Per Share | 8.78 | 9.63 | -23.57 | -20.22 | -11.67 |
| Tangible Book Value | 673.17 | 733.38 | -123.1 | -77.69 | -42.62 |
| Tangible Book Value Per Share | 8.60 | 9.63 | -23.57 | -20.22 | -11.67 |
Source: S&P Capital IQ. Standard template.
Financial Sources.